Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma

Clinical trial NCT07373990 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07373990
Sponsor: Sun Yat-sen University
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Nasopharyngeal Cancinoma (NPC)Nasopharyngeal Cancer

Start date: 2026-01-15
Primary completion: 2028-04-30
Enrollment: 418

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.